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Objective: This study was aimed to evaluate the prevalence of pertussis in adolescents and
adults  with cough lasting more than 14 days and less than 30 days.
Methods:  This is a prospective observational study in interepidemic period of pertusis. Ten
public  health outpatient clinics in the city of Recife, Brazil, were  randomly selected for the
study.  The study population consisted of individuals aged 10 years and over with cough that
had lasted between 14 and 30 days. Nasopharyngeal swabs were  collected for culture and
PCR  in order to identify Bordetella pertussis. We  adopted the Centers for Disease Control and
Prevention  in the US (CDC) deﬁnition of cases of pertussis.
Results: A total of 192 individuals were identiﬁed as suspected cases. Their mean age was
40.7  years. Pertussis was conﬁrmed in 10 of the 192 suspected cases, with an estimated
prevalence  of 5.21% (95% conﬁdence interval 2.03–8.38). All cases met the clinical case deﬁ-
nition for pertussis; one suspect had both culture and PCR positive. PCR conﬁrmed 100% of
the cases, 7/10 by PCR and 3/10 by epidemiological linkage with a case conﬁrmed by PCR.Conclusion: During an interepidemic period, 1 in 20 cases of prolonged cough had pertussis,
suggesting  this is an important cause of prolonged cough in adolescents and adults.
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Introduction
Epidemics of pertussis, an increase in of the number of per-
tussis  cases in adolescents, adults and infants younger than
six  months of age have been reported in several regions of the
world.1–3 Adolescents and adults have often been identiﬁed
as  the main source of pertussis outbreaks amongst house-
hold  members.4–6 The World Health Organization estimates
that  there were  around 16 million cases of pertussis and
195,000  deaths worldwide, 95% of which were  in developing
countries.2
The clinical presentation of pertussis in adolescents and
adults  is often atypical, with a prolonged, persistent, nonspe-
ciﬁc  cough and in these age groups the diagnosis of pertussis is
seldom considered.7–9 Although many  studies have reported
that  prolonged cough in adolescents and adults may  be per-
tussis,  the actual prevalence of pertussis in this age group
remains  underestimated.2 In 2010, the Centers for Disease
Control  and Prevention in the US (CDC) registered 27,550 cases
of  pertussis in the US, and in Europe the European Center for
the  Control and Prevention of Diseases registered 15,749 cases,
with a higher prevalence in adolescents between the ages of
10  and 14 years.10,11 In studies conducted in different regions
of  the world the prevalence of pertussis amongst adolescents
and  adults with prolonged cough has varied from 10% to
32%.9,12,13 The variety of diagnostic methods and case deﬁni-
tions  used may  be one of the major reasons for the differences
in  the observed prevalence.7,9,14,15 Nonetheless, these studies
have  contributed to strategies for controlling the surveillance
of  pertussis in these countries.2,10,11
In Brazil, since the introduction of the pertussis vaccine
in  1980, the number of reported cases fell sharply with a
sustained  downward trend. However in 2011, 583 cases of per-
tussis  were  conﬁrmed. Amongst the conﬁrmed cases, 76.3%
were  infants under 1 year of age, the group with highest
incidence and mortality rates.16 In the city of Recife, most
notiﬁcations of pertussis are hospitalized cases. A study car-
ried  out in Recife identiﬁed that adults and adolescents older
than  11.5 years were  the source of infections for 70% of per-
tussis  cases.4 However, this study analyzed cases of pertussis
in  adult contacts of children with pertussis.17
This study is aimed to evaluate the prevalence of pertussis
in  adolescents and adults with cough lasting more  than 14
days  and less than 30 days.
Methods
This is a prospective observational study in interepidemic
period of pertussis. The study was  conducted in 10 public
health  outpatient clinics in the city of Recife, Brazil. The out-
patient  clinics from within the city’s six Health Districts were
randomly  selected with proportional probability of the num-
ber  of patients attended. Health professionals and individuals
attending the health clinics were  informed of the study. During
the  period from August 2010 to July 2011, those over the age of
10  years, with cough lasting more  than 14 days and less than
30  days were  identiﬁed. Nasopharyngeal swabs for culture
and  PCR were  collected from all participants. Individuals who 0 1 5;1  9(1):43–46
were immunocompromised, suffered from TB, had chronic
bronchitis, other chronic diseases with cough, or using drugs
that  cause coughing were  excluded from the study. A sus-
pected  case of pertussis was  considered as a conﬁrmed case if
the individual presented a cough and a positive nasopharyn-
geal  swab culture, or met  the clinical case deﬁnition criteria
for  pertussis and had a positive PCR. The criteria for deﬁn-
ing  a clinical case of pertussis were: a cough for more  than
14  days, associated with at least one other symptom: parox-
ysmal  cough, inspiratory whooping, post-tussive vomiting
regardless of age and vaccination status. An epidemiologi-
cally conﬁrmed case was  considered when the individual met
the  clinical criteria of a pertussis case, had a negative culture
and/or  PCR, but was  in contact with an individual with per-
tussis  conﬁrmed by culture or PCR. Material for the culture
and  PCR was  collected by nasopharyngeal swab from indi-
vidual  nostrils for each procedure. The swabs for collecting
the  culture were inoculated in a transport medium of 50% of
the  Regan-Lowe concentration medium (Oxoid Ltd., Columbia,
MD)  for the culture and for the laboratory in a Reagan Lowe
medium  (Oxoid. Ltd., Columbia, MD), made selective by the
addition  of 40 mg/L cephalexin. The colonies suspected as
being  B. pertussis were conﬁrmed by biochemical tests. The
real-time  PCR used primers and TaqMan® probes, speciﬁ-
cally  for the IS 481 region.14,18,19 The study was  approved
by the Ethics Committee at Hospital Oswaldo Cruz, regis-
tration  number 029/2008. All participants signed the Terms
of  Free, Informed Consent. Data were coded and processed
using  Epi-info 6.0.4 (CDC). The descriptive analysis of the
data  was  conducted by frequency distribution and the means
with  the respective standard deviations. In the comparative
age  analysis of the suspected cases, according to positivity
for  pertussis, the student t-test was  applied to independent
samples tested for normality by the Komogorov–Smirnov test.
In  the analysis of associations, when the independent vari-
able  was  categorical, the Fisher’s exact test was  applied.
The  statistical signiﬁcance adopted for the study was 5%
(p  < 0.05). A prevalence of 25% was  assumed for calculating
the  sample size, an acceptable maximum error of 6% and a
conﬁdence  interval of 95%. The estimated required sample
was  201 patients. The study was conducted in 10 outpa-
tient  clinics from amongst the 12 randomly selected clinics.
Two  clinics were excluded since it was  not possible to select
patients  due to operational difﬁculties. The patients identi-
ﬁed  at the excluded clinics were transferred to other clinics
in  the same district, which made part of the selected clin-
ics  and corresponded to 5.26% (10/192) of the selected sample
total.
Results
A total of 192 individuals were  identiﬁed aged over 10 years
and  with cough lasting for more  than 14 days. The mean age
was  40.7 years, ranging from 10 to 84 years and a SD ± 17.8
years.  Of these, 55.7% (107/192) were over 40 years of age,
27.6%  (53/192) were aged between 20 and 39 years and 16.7%
(32/192)  between 10 and 19 years. A total of 70.0% (134/192)
of  the suspected cases were female; 182/192 of the suspected
cases  were unable to inform their vaccination status. The
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Table 1 – Criteria for conﬁrming the diagnosis of
pertussis in adolescents and adults with a prolonged
cough.
Positive for pertussis
Positive (%) 95% CI
Criteria for conﬁrmation
Culture  1/10 10% 0.25–44.5%
Real-time  PCR 7/10 70% 34.7–93.3%
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The  high prevalence found is relevant because adults and ado-Epidemiological linkage 3/10 30% 6.7–65.2%
emaining 10 individuals who reported having received the
-dose  DPT vaccine were  aged between 10 and 19 years. Of
he  10 conﬁrmed pertussis cases, the vaccination status was
eported  by three individuals, two conﬁrmed that they had
eceived  four doses of DPT, and one conﬁrmed three doses.
f  these, one was  diagnosed with pertussis by culture and
CR,  and the others, by PCR. Of the 192 suspected pertus-
is  cases, 171/192 (89%) reported cough of between 14 and
1  days and 21/192 (11%) for more  than 21 days. Inspira-
ory whooping was  reported by 120/192 (62.5%), cyanosis by
7/192  (14.1%) and post-tussive vomiting by 152/192 (79.1%).
mongst  the 192 suspected cases, pertussis was conﬁrmed
n  10 individuals, thus estimating a prevalence of 5.21% (95%
I  2.03–8.38). The culture and PCR were  positive for B. pertus-
is  in one patient (Table 1) and all conﬁrmed cases by PCR
pidemiologically met  the clinical criteria for deﬁning a case
f  pertussis. The clinical characteristics and epidemiological
escriptions of the 10 pertussis conﬁrmed cases are in Table 2.
mongst  the 10 conﬁrmed cases of pertussis, ﬁve were pri-
ary  cases, four were  co-primary and one was secondary. Of
hese, ﬁve were  index cases that led to the identiﬁcation of
ve  new cases.
iscussion
ne in 20 cases of prolonged cough was  found to have per-
ussis.  This study was  conducted during an interepidemic
eriod.16 This fact may  possibly have inﬂuenced the num-
er  of individuals eligible for the study and in estimating
he prevalence of pertussis. The mean age of the individuals
ith  a cough for more  than 14 days was  40.7 years. Studies
Table 2 – Clinical and epidemiological characteristics of adolesc
with pertussis.
Cases 1 2 3 4 
Sex F F F M 
Age (years) 28 14 20 43 
Days with cough 18 14 15 20 
Paroxysm + + + + 
Whoop − + + + 
Cyanosis − − − − 
Apnea + − − − 
Post-tussive vomiting + + + + 
Vaccinationa 3 1 2 3 
F: female; M: male.
a Vaccination: 1 – complete vaccination (4 doses DTP); 2 – incomplete vacc 1 5;1  9(1):43–46  45
undertaken in Canada, Denmark and France reported a mean
age  of between 41 and 49 years. In the present study, only
10  patients were  able to inform whether they had taken DPT
vaccine  against pertussis. Of these, one was  diagnosed with
pertussis  by culture and PCR and the others by PCR. As the par-
ticipants  of this study were aged over 10 years, the ﬁnal dose
of  the vaccine for pertussis would have been applied at least 8
years previously. The pertussis vaccine was ﬁrst introduced
into  the Brazilian vaccine program in 1983 and since 2003;
vaccine  coverage for three doses of the vaccine has remained
above  95%.16 In around 90% of the suspected cases, the cough
had  lasted for a period of 14–21 days and 110 (57.29%) met  the
clinical  criteria for pertussis. Gilberg et al., in France, during
a  period of low prevalence of pertussis, reported that 79% of
conﬁrmed  cases met  the clinical criteria. Strebel, in the US,
observed  that 85% of conﬁrmed cases of pertussis met  clini-
cal  criteria.12 The high prevalence of cases that met  clinical
criteria may  be explained by the fact that those with more
severe  symptoms were more  likely to seek medical care. This
in  turn, could explain why the prevalence of pertussis in ado-
lescents  and adults who present cough as the only symptom
is  underestimated. Culture only conﬁrmed the diagnosis in
just  one of the ten patients with pertussis (10%). PCR con-
ﬁrmed  100% of the cases. Several studies have demonstrated
low  culture sensitivity for conﬁrming a case of pertussis as
compared  to PCR and blood tests.14,16,19 The patients included
in  the present study had cough for more  than 14 days. It is
believed  that the timing of culture collection and the techni-
cal  difﬁculties involved in conducting the test contributed to
the  low sensitivity of the study. The present study estimated a
prevalence of pertussis of 5.21% in adolescents and adults with
cough  for more  than 14 days. Studies conducted in Australia,
Canada, Denmark, France and the US reported prevalence
ranging from 10% to 32%.8,9,11 As this study was  carried out
during  an interepidemic period, did not use serology to con-
ﬁrm  the diagnosis, and that the material for the culture and
PCR  was collected between 14 and 30 days after the onset of
cough,  may  have underestimated the prevalence of pertussis
resulting  in a lower prevalence than that in other countries.lescents  are the main source of infection for infants under
1  year of age, the age when pertussis has the higher rate of
complications and death.1,3,5–7
ents and adults with a prolonged cough and diagnosed
5 6 7 8 9 10
M F F M F M
43 45 15 29 34 24
14 14 14 15 14 18
+ + + + + +
+ + + + + +
− − + + − −
− − + + + +
+ − − − − −
3 3 1 3 3 3
ination (minor than 3 doses DTP); 3 – unknown.
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Conclusion
Even in an interepidemic period, pertussis was  shown to cause
one  in 20 cases of prolonged cough in adolescents and adults.
Recommendation
Pertussis is underdiagnosed among adolescents and adults.
Health  professionals should be more  aware and have high
index  of suspicion to recognize pertussis as cause of cough
illness,  even in the absence of local outbreak. The implemen-
tation  of adolescents and adults immunization could protect
the  infants.
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